In multiple myeloma, mesenchymal stem cells facilitate immune evasion through the secretion of cytokines, including IL-6 and CCL2, which enhance the survival and proliferation of multiple myeloma cells while suppressing immune cell activity. Here, IL6 is linked to plasma cell myeloma.